Siemens Hit With UPC Sales Ban Over Breast-Screening Tech
Europe's patent court has ruled that a Siemens breast cancer screening system infringes a Hologic patent, granting the rival an injunction despite Siemens' claims that it would be disproportionate to recall...To view the full article, register now.
Already a subscriber? Click here to view full article